Bioscience Animal Health PCL (BKK:BIS)
Thailand · Delayed Price · Currency is THB 1.940
+0.040 (2.11%)
Feb 6, 2026, 11:42 AM ICT
BKK:BIS Cash Flow Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 65.05 | 65.04 | 50.71 | 55.92 | 72.4 | 62.23 |
Depreciation & Amortization | 19.95 | 17.78 | 16.04 | 15.72 | 17.37 | 14.57 |
Other Amortization | 0.91 | 0.91 | 0.41 | - | - | - |
Loss (Gain) From Sale of Assets | -0.01 | -0.53 | -1.1 | -10.3 | -0.5 | 0.41 |
Asset Writedown & Restructuring Costs | 0.28 | - | 0.34 | 0.02 | 0.77 | 0.55 |
Loss (Gain) From Sale of Investments | -0.95 | -0.04 | -0.04 | -0.21 | -0.27 | 10.44 |
Loss (Gain) on Equity Investments | - | - | - | - | -0.3 | -3.37 |
Stock-Based Compensation | - | - | - | - | - | 9.82 |
Provision & Write-off of Bad Debts | 1.03 | 3.8 | 5.78 | -4.75 | 0.67 | 17.47 |
Other Operating Activities | 18.61 | 16.53 | 4.99 | 8.58 | -9.39 | 15.78 |
Change in Accounts Receivable | 76.2 | 14.76 | -86.99 | -32.01 | -3.11 | -25.73 |
Change in Inventory | -2.6 | 80.08 | -71.97 | -49.92 | -45.7 | -24.74 |
Change in Accounts Payable | 115.07 | -61.41 | 107.73 | -27.29 | 4.64 | -73.78 |
Change in Other Net Operating Assets | -12.66 | -32.5 | -48.46 | 11.49 | 0.15 | 18.77 |
Operating Cash Flow | 280.87 | 104.4 | -22.56 | -32.74 | 36.73 | 22.42 |
Operating Cash Flow Growth | 870.61% | - | - | - | 63.83% | -87.72% |
Capital Expenditures | -2.9 | -5.91 | -6.1 | -14.51 | -18.24 | -24.28 |
Sale of Property, Plant & Equipment | 0.01 | 1.33 | 0.27 | 0.37 | 0.5 | 1.36 |
Cash Acquisitions | - | -11.08 | - | - | - | -42.64 |
Divestitures | - | - | - | - | - | 0.26 |
Sale (Purchase) of Intangibles | -0.62 | -1.13 | -2.3 | -3.08 | -0.13 | -0.46 |
Sale (Purchase) of Real Estate | -0.05 | -0.22 | 4.19 | 28.31 | -0.29 | -4 |
Investment in Securities | -224.09 | 14.94 | 61.77 | -254.77 | 2.27 | 21.76 |
Other Investing Activities | 2.12 | 0.88 | 3.76 | 101.1 | 0.45 | -2.08 |
Investing Cash Flow | -225.54 | -1.19 | 61.59 | -142.58 | -15.44 | -50.08 |
Short-Term Debt Issued | - | 44 | - | - | 111.61 | 37.63 |
Long-Term Debt Issued | - | - | - | - | 25 | 48 |
Total Debt Issued | 37.34 | 44 | - | - | 136.61 | 85.63 |
Short-Term Debt Repaid | - | - | - | -254.75 | -39.63 | -31.09 |
Long-Term Debt Repaid | - | -6.06 | -3.2 | -51.76 | -47.26 | -49.67 |
Total Debt Repaid | -51.34 | -6.06 | -3.2 | -306.5 | -86.89 | -80.76 |
Net Debt Issued (Repaid) | -14 | 37.94 | -3.2 | -306.5 | 49.72 | 4.87 |
Issuance of Common Stock | - | - | - | 564 | - | 30 |
Common Dividends Paid | -53.38 | -37.68 | -32.19 | -109.04 | -22 | -69.7 |
Other Financing Activities | -0.89 | 0.4 | -0.86 | -23.16 | -2.15 | -9.59 |
Financing Cash Flow | -68.27 | 0.66 | -36.25 | 125.3 | 25.57 | -44.43 |
Foreign Exchange Rate Adjustments | -1.09 | -1.09 | 0.08 | - | - | - |
Net Cash Flow | -14.02 | 102.79 | 2.86 | -50.02 | 46.86 | -72.09 |
Free Cash Flow | 277.98 | 98.5 | -28.66 | -47.25 | 18.49 | -1.86 |
Free Cash Flow Margin | 11.98% | 4.15% | -1.18% | -2.14% | 0.93% | -0.10% |
Free Cash Flow Per Share | 0.89 | 0.31 | -0.09 | -0.17 | 0.08 | -0.01 |
Cash Interest Paid | 1.79 | 0.85 | 1.8 | 6.38 | - | 9.59 |
Cash Income Tax Paid | 23.87 | 21.65 | 12.18 | 16.39 | 30.91 | 15.86 |
Levered Free Cash Flow | 262.06 | 109.59 | -34.37 | -64.72 | -0.58 | -89.07 |
Unlevered Free Cash Flow | 263.25 | 111.23 | -33.19 | -60.8 | 5.64 | -83.4 |
Change in Working Capital | 176.01 | 0.92 | -99.7 | -97.72 | -44.02 | -105.49 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.